Product Wiki · Recalls · Health Canada — Medical Devices

Vitros Chemistry Products System - Crp Slides (C-Reactive Protein) — recall 76455

Health Canada — Medical Devices · Canada · 2024-11-06 · Type II

Compiled from an official source — the facts on this page are reproduced from the issuing authority’s own published notice, which is linked above. No AI-generated text appears on this page. How we use AI →
Agency
Health Canada — Medical Devices
Recall identifier
76455
Date of alert
2024-11-06
Country / jurisdiction
Canada
Risk level
Type II
Risk type
recall
Product category
Immunology
Product type
Medical devices
Notice status
Archived by the issuing authority — kept for reference
Reported risk: QuidelOrtho™ received complaints on the affected coating of VITROS® CRP slides, related to lower-than-expected results when testing patient samples known to have elevated concentrations of CRP (>90 mg/l or >9 mg/dl). When tested neat, results were reported as being within the upper end of the measuring range (70-90 mg/l or 7-9 mg/dl) however, upon dilution, results for these samples were reported as having concentrations greater than 2x the neat result. Patient samples with a CRP concentration above 90 mg/l (9 mg/dl) (typically above 150 mg/l (15 mg/dl)) may be reported as falsely reduced when samples are tested neat, with the dilute sample results predicting greater than 2x greater than the neat result. The observed bias will vary; however, the predicted neat CRP results will generally range between 70-90 mg/l (7-9 mg/dl). Recall start date: October 25, 2024
Primary source: https://recalls-rappels.canada.ca/en/alert-recall/vitros-chemistry-products-syst

Verify each fact at the issuing agency before acting. Recall scope, affected lots, and remediation instructions may be updated by the agency after our last sync.

Related

ProductGuru indexes recall and safety-alert records from ~30 public agency registries. We are not lawyers, regulators or product-safety consultants. This page restates what the named agency published; consult the primary source above (or qualified counsel in your jurisdiction) before any commercial, medical or safety decision.